Novo Nordisk reported 10.17 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Bausch Health Companies 12.85 0 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Eli Lilly 32.9 7.37 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Merck 32.26 15.74 Jun/2026
Novartis 22.41 2.24 Jun/2026
Novo Nordisk 10.17 2.61 Jun/2026
Novo Nordisk 9.94 0.47 Jun/2026
Pacira 35.68 2.9 Jun/2026
Sanofi 18.96 7.12 Jun/2026
Supernus Pharmaceuticals 65.37 21.16 Jun/2026